Rare success for Alzheimer's research unlocks hope for future therapies
Drugmakers Eisai and Biogen reported in September that their therapy lecanemab could slow progress of the disease by 27%
0
Drugmakers Eisai and Biogen reported in September that their therapy lecanemab could slow progress of the disease by 27%
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now